T1	Participants 48 69	H. pylori eradication
T2	Participants 414 569	multicenter, open-label, pilot study enrolling consecutive non-ulcer dyspepsia patients with H. pylori infection never previously treated for the infection
T3	Participants 1397 1488	270 patients were enrolled, but 13 patients early interrupted treatment due to side effects
